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Abstract
Background: The relationship between smoking and risk of kidney failure, especially in people of Chinese origin, is not clear.
We analyzed data from the Singapore Chinese Health Study to investigate whether smoking increases the risk of kidney
failure.
Methods: The Singapore Chinese Health Study is a population-based cohort of 63,257 Chinese adults enrolled between
1993 and 1998. Information on smoking status was collected at baseline. Incidence of kidney failure was identified via
record linkage with the nationwide Singapore Renal Registry until 2008. Kidney failure was defined by one of the following:
1) serum creatinine level of more than or equal to 500 mmol/l (5.7 mg/dl), 2) estimated glomerular filtration rate of less than
15 ml/min/1.73 m2, 3) undergoing hemodialysis or peritoneal dialysis, 4) undergone kidney transplantation. Cox
proportional hazard regression analysis was performed for the outcome of kidney failure after adjusting for age, education,
dialect, herbal medications, body mass index, sex, physician-diagnosed hypertension and diabetes mellitus.
Results: The mean age of subjects was 55.6 years at baseline, and 44% were men. Overall 30.6% were ever smokers (current
or former) at baseline. A total of 674 incident cases of kidney failure occurred during a median follow-up of 13.3 years.
Among men, smokers had a significant increase in the adjusted risk of kidney failure [hazard ratio (HR): 1.29; 95% CI: 1.02–
1.64] compared to never smokers. There was a strong dose-dependent association between number of years of smoking
and kidney failure, (p for trend= 0.011). The risk decreased with prolonged cessation (quitting$10 years since baseline). The
number of women smokers was too few for conclusive relationship.
Limitation: Information on baseline kidney function was not available.
Conclusions: Cigarette smoking is associated with increased risk of kidney failure among Chinese men. The risk appears to
be dose- and duration-dependent and modifiable after long duration of cessation.
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Introduction
Kidney failure is a rising public health problem globally with
high morbidity and reduced quality of life. [1–3]. The rapid
increase in number of people with kidney failure, including those
requiring or nearing the need for expensive renal replacement
therapy, is in part due to the aging populations coupled with
prolonged exposure to risk factors for kidney failure. [4] Smoking
is recognized as one of the leading causes of preventable deaths
globally predominantly from cardiovascular disease and cancer.
[5] Evidence from European origin population indicates that
smoking may be associated with progression of chronic kidney
disease (CKD), especially in men. [6] However, there is scarcity of
evidence on the relationship of smoking with kidney failure in non-
European origin populations. Moreover, it is not known whether
any potential relationship between smoking and kidney failure is
dose-dependent, and, if so, is it modifiable. Asian populations have
been shown to have greater susceptibility to CKD than European
counterparts by virtue of a greater burden of many key risk factors,
and there is evidence that CKD progresses to kidney failure faster
in Asians. [7] Furthermore, the burden of kidney failure is
increasing rapidly in many Asian countries where implementation
of tobacco control policies has been challenging. [4,8] However, it
is unclear how smoking plays a role in the onset of kidney failure in
Asians.
A clear understanding of the nature of association between
smoking and kidney failure would be important for enhancing the
understanding the epidemiology of CKD and for boosting
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smoking prevention and cessation efforts, especially among
individuals at high risk for kidney failure in Asia.
We therefore analyzed data from the Singapore Chinese Health
Study linked with the Singapore Renal Registry which maintains a
record of all patients with kidney failure, treated with renal
replacement therapy or managed conservatively, with the follow-
ing objectives: 1) To determine the association between cigarette
smoking status at baseline (former or current) with risk of kidney
failure; 2) to assess whether there is a dose-dependent relationship
between smoking intensity and duration and kidney failure risk,
and 3) to assess whether quitting smoking reduces the risk of
kidney failure.
We hypothesized that smoking would increase the risk of kidney
failure; and that this risk would be dose dependent and modifiable
with smoking cessation in men of Chinese origin.
Methods
Study Population
The Singapore Chinese Health Study is a population-based
prospective cohort established between April 1993 and December
1998 through the recruitment of 63,257 Chinese men (n= 27,959)
and women (n = 35,298), who were aged 45–74 years, and residing
in public housing estates, where 86% of Singapore resided at that
time. All participants belonged to one of the two major dialect
groups, Hokkien or Cantonese, who originated from two
contiguous prefectures in southern China. At recruitment, after
obtaining informed consent, each study subject was interviewed in
person by a trained interviewer using a structured questionnaire,
which focused on history of tobacco and alcohol use, current diet,
current physical activity, menstrual and reproductive history in
women, medical history, and family history of cancer. Current diet
was assessed using a validated 165-item, semi-quantitative food
frequency questionnaire. [9] The Institutional Review Board at
the National University of Singapore approved this study. Written
informed consent was obtained from all participants.
Exposure Assessment
For cigarette smoking, the study population was divided into
never, former and current smokers based on their choice of three
possible responses to the following question, ‘‘Have you ever
smoked at least one cigarette a day for 1 year or longer’’. Subjects
who answered ‘‘no’’ were classified as ‘‘never-smokers’’, those who
answered ‘‘yes, but I quit smoking’’ were classified as ‘‘former
smokers’’, and those who answered ‘‘yes, and I currently smoke’’
were classified as ‘‘current smokers’’. Ever smokers (former or
current) were then asked about age at smoking initiation (four
categories: less than 15, 15–19, 20–29, and 30 years or older);
number of cigarettes smoked per day (six categories: 6 or less, 7–
12, 13–22, 23–32, 33–42, and 43 or more); and duration of
smoking (five categories; less than 10, 10–19, 20–29, 30–39, 40 or
more years). Former smokers were also asked how long they had
quit smoking (seven categories; less than 1 year, 1–2 years, 3–4
years, 5–9 years, 10–14 years, 15–19 years, 20 or more years).
Case Ascertainment
Identification of incident kidney failure and deaths among
cohort members was accomplished by record linkage analysis of
the cohort database with the population-based Singapore Renal
Registry. The nationwide renal registry has been in place since
1993 and has been shown to be comprehensive in its recording of
kidney failure cases since 1999. [10] The registry defines kidney
failure by at least one of these criteria: 1) serum creatinine level of
more than or equal to 500 mmol/l (5.7 mg/dl) 2) estimated
T
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glomerular filtration rate (GFR) of less than 15 ml/min/1.73 m2
(based on either the Modification of Diet in Renal Disease
(MDRD) Study equation, Cockcroft Gault equation, or 24 hour
creatinine clearance) 3) undergoing hemodialysis or peritoneal
dialysis, 4) had undergone kidney transplant. All cases are then
classified by disease etiology based on review of medical records.
As of April 2008, only 27 cases were known to be lost to follow-up
due to migration out of Singapore. As of 31 Dec 2008, 94
participants had kidney failure diagnosed before recruitment and
were excluded from the analysis. A total of 674 incident kidney
failure cases were identified from the remaining 62,583 partici-
pants included in the analyses. Among them, 56.9% had diabetic
nephropathy, 15.7% primary glomerulonephritis and 12.7%
nephrosclerosis.
Statistical Analysis
Since the development of kidney failure follows a chronic
process over time, we examined baseline characteristics of the
entire cohort by duration of smoking for men and women. For
each study subject, person-years were counted from the date of
baseline interview to the date of kidney failure diagnosis, the date
of death, date of last contact (for the few subjects who migrated out
of Singapore) or December 31, 2008, whichever occurred first.
The incidence rate of kidney failure was computed and 95% CI
were generated using Poisson distribution.
Univariable and multivariable regression models were con-
structed and Cox proportional hazards regression analysis was
performed to examine the associations between cigarette smoking
and risk of developing kidney failure. Deaths from competing
causes (ie non kidney failure deaths) were censored in the time to
event analysis for the primary outcome of kidney failure. We first
examined the association of current and former smokers, and
number of cigarettes smoked with kidney failure in the entire
cohort. The number of cigarettes smoked was grouped into 3
categories of 12 or less per day, 13–22/day, or 23 or more per day.
Since studies in other populations have provided sex-specific
estimates [6], our subsequent main analyses were stratified for men
and women. To increase power of association with smoking status,
we grouped former and current smokers as ‘‘ever’’ smokers. The
duration of smoking (,19 years; 19–39 years, 40 years or more)
and time since quitting (quit for 1 year or less, quit .1–9 years,
and quit for 10 years or more) were regrouped into 3 categories
each per distribution of data. The associations were measured by
Table 3. Risk of Kidney Failure by Smoking Status in Singapore Chinese Cohort Study.
Smoking status Number Kidney Failure *Adjusted HR (95% CI)
Never smoker (n =43859) 443 1.00
Former smoker (n=6976) 108 1.42 (1.07–1.87)
Current smoker (n=12327) 122 1.28 (0.98–1.65)
P trend 0.04
Never smoker (n =43859) 443 1.00
Ever smoked ,=12 cigarettes/day (n=7693) 95 1.27 (1.00–1.61)
Ever smoked 13–22 cigarettes/day (7331) 76 1.15 (0.88–1.50)
Ever smoked .=23 cigarettes/day (n=4280) 60 1.37 (1.01–1.84)
P trend 0.03
*Model adjusted for age, body mass index, dialect (Hokkein, Cantonese), education level, history of physician diagnosed hypertension, diabetes, known heart disease or
stroke, alcohol use and intake of ginseng.
doi:10.1371/journal.pone.0062962.t003
Table 4. Unadjusted & Adjusted Risk of Kidney Failure in Chinese Men and Women by Smoking Status.
Men Women
Smoking Status
Unadjusted Hazard
Ratio (95% CI)
*Multivariable
Adjusted Hazard
Ratio (95% CI)
Unadjusted Hazard Ratio
(95% CI)
*Multivariable Adjusted
Hazard Ratio (95% CI)
Never vs 1.00 1.00 1.00 1.00
Ever 1.28 (1.01–1.61) 1.29 (1.02–1.64) 1.51 (1.10–2.08) 1.18 (0.85–1.62)
Never Smoker vs 1.00 1.00 1.00 1.00
Duration of smoking ,19 years 1.26 (0.83–1.91) 1.17 (0.77–1.78) 1.37 (0.65–2.90) 1.19 (0.56–2.51)
Duration of smoking 20–39 years 1.08 (0.82–1.43) 1.19 (0.90–1.58) 1.70 (1.09–2.64) 1.28 (0.82–2.00)
Duration of smoking .40 years 1.65 (1.23–2.21) 1.56 (1.13–2.14) 1.37 (0.81–2.29) 1.04 (0.62–1.76)
P trend 0.007 0.011 0.019 0.435
Never smoker was defined as those who have not ever smoked at least one cigarette a day for 1 year or longer.
Ever smoker was defined as those who have ever smoked at least one cigarette a day for 1 year or longer.
*Model adjusted for age, body mass index, dialect (Hokkein, Cantonese), education level, history of physician diagnosed hypertension, diabetes, known heart disease or
stroke, alcohol use and intake of ginseng.
doi:10.1371/journal.pone.0062962.t004
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hazard ratios (HRs) and their corresponding 95% confidence
intervals (CIs) and p values (two-sided).
In the analysis considering smoking and kidney failure, the
model included the following baseline covariates: age, body mass
index, dialect (Hokkein, Cantonese), education level, history of
physician diagnosed hypertension, diabetes, known heart disease
or stroke, alcohol use and intake of ginseng. These factors are
known to be associated with kidney failure in other studies. [11,12]
For the analysis by duration of smoking and smoking cessation, we
performed tests for trend by entering ordinal categorical variables
as continuous variables in the Cox regression models. We also
tested for interaction between age and duration of smoking,
number of cigarettes smoked with age at initiation of smoking. We
performed analyses for the whole population and also for men and
women separately. Sensitivity analysis were performed after
retaining the original categories of smoking status as in the
questionnaire for years of smoking (five categories) and quit
smoking (seven categories), and after excluding kidney failure cases
occurred within first 5 years post-enrollment, to reduce the impact
of outcome on the change of smoking behavior, as above.
All regression analyses were conducted using SAS statistical
software version 9.2 (SAS institute, Cary, NC). Two-sided Ps
,0.05 were considered statistically significant.
Results
Of the 63163 subjects, 44.1% were men. Among men, 41.9%
were never smokers, and 8.3%, 30.3%, and 19.6% smoked for
,19, 19–39, and 40 years or more, respectively. Among women,
91.1% were never smokers, and 1.5%, 3.6%, and 3.6% smoked
for ,19, 19–39, and 40 years or more. Table 1 shows baseline
characteristics of the participants by duration of smoking. Men
who smoked were more likely to be less educated, consume
alcohol, have diabetes, heart disease and stroke, and these
associations were stronger with longer duration of smoking.
During a median follow-up of 13.3 year, and 774,434 person
years, 674 (1%) developed incident kidney failure with an overall
crude incidence rate of 0.87 (0.81–0.94) per 1000 person years
(Table 2), and age-standardized incidence rate of 0.83 per 1000
person years.
The hazard rates (95% CI) of kidney failure by smoking status
are shown in Tables 3, 4, and 5. In the entire cohort, smoking was
associated with increased risk of kidney failure [hazard ratio (HR),
1.42; 95% confidence interval (CI): 1.07–1.87] for former smokers,
and [HR (95% CI): 1.28 (0.98–1.65)] for current smokers: [p for
trend= 0.04], adjusted for age, body mass index, dialect,
education level, history of physician diagnosed hypertension,
diabetes, known heart disease or stroke, alcohol use and intake of
ginseng compared to never smokers. The risk increased with
increased number of cigarettes (p for trend= 0.03) (Table 3).
Among men, ever smokers had a significant increase in the risk of
kidney failure [adjusted HR (95% CI): (1.29 1.02–1.64)],
compared to never smokers (Table 4). There was a strong dose-
dependent association between duration of smoking and kidney
failure (p for trend= 0.011). Men who had smoked for 40 years or
more at baseline had significantly increased adjusted risk of kidney
failure compared to men who never smoked [HR (95% CI): 1.56
(1.23–2.21)]. These relationships seemed to be similar in women
with unadjusted hazard rate of kidney failure was [HR (95% CI)]
1.51 (1.10–2.08)] in ever versus never smokers, and with increasing
duration of smoking (p for trend 0.01), albeit the adjusted risks
were not statistically significant. As shown in Table 5, the risk of
kidney failure remained significantly elevated even 1–9 years after
smoking cessation. However, the adjusted HR decreased to 1.02 at
10 years or greater after quitting. A similar pattern was observed in
women, albeit no significant association was observed in the
adjusted model due to small case numbers among women.
Finally, the sensitivity analysis revealed consistent results with
respect to the main associations as well as the dose dependency of
the relationship between smoking and kidney failure, and the
threshold of 10 years since quitting for the risk to reduce
substantially.
Discussion
Our in-depth analysis data on 63,163 subjects followed over a
median of 13.3 years with 674 incident kidney failure in the
Singapore Chinese Health Study showed an increased risk of
kidney failure that correlated with duration of smoking in men.
The adjusted risk estimate decreased in men who quit smoking
Table 5. Association of smoking cessation with Kidney Failure in Singapore Chinese Health Study.
Smoking Status N Person years
Number Kidney
Failure
Unadjusted Hazard Ratio
(95% CI)
Multivariable **Adjusted Hazard
Ratio (95% CI)
Men
Never Smoker vs. 11705 144623 115 1.00 1.00
Quit smoking ,1 year 20633 19 1.18 (0.73–1.92) 1.26 (0.77–2.08)
Quit smoking 1–9 years 1856 26472 45 2.17 (1.54–3.06) 1.83 (1.29–2.60)
Quit smoking .10 years 2333 37880 40 1.36 (0.95–1.95) 1.02 (0.71–1.47)
P trend 3301 0.002 0.22
Women
Never Smoker vs. 32152 407106 326 1.00 1.00
Quit smoking ,1 year 234 2636 3 1.45 (0.46–4.50) 1.25 (0.40–3.91)
Quit smoking 1–9 years 353 3846 9 2.15 (1.55–5.82) 1.61 (0.83–3.14)
Quit smoking .10 years 445 4929 5 1.33 (0.55–3.20) 0.79 (0.32–1.92)
P trend 0.003 0.72
*Model adjusted for age, body mass index, dialect (Hokkein, Cantonese), education level, history of physician diagnosed hypertension, diabetes, known heart disease or
stroke, alcohol use and intake of ginseng.
doi:10.1371/journal.pone.0062962.t005
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after prolonged cessation, although it was still significantly elevated
in those who had quit for less than 10 years. The direction of
relationship between smoking and kidney failure were similar in
women however the numbers were too small to be conclusive.
Our findings in Chinese men are consistent with observations of
the Multiple Risk Factor Intervention Trial (MRFIT) which
studied 332,544 men and documented that smoking was signifi-
cantly associated with an increased risk for kidney failure [11].
Our study is novel in demonstrating the dose-relationship between
smoking and kidney failure in non-European origin population
(unadjusted p trend 0.007, adjusted p trend= 0.01). This
association has been previously documented between number of
cigarettes smoked and albuminuria and decline in kidney function,
however not with the hard outcome of kidney failure. [13] Our
results are also among the first to suggest that prolonged smoking
cessation .10 years since baseline may reduce this risk back to the
level of a non-smoker (HR=1.02 (0.71–1.47) (Table 5, column 4,
row 1). This finding is consistent with those recently reported in
Europeans in the HUNT Study. [6] However, we did not find a
clear graded trend with increasing years of smoking cessation and
kidney failure (adjusted trend p= 0.22) indicating the possibility of
a threshold duration. Overall, these findings support the notion of
shared risk factors for CVD and kidney disease. [14] However,
they also contrast with the effects of smoking on CVD which have
been shown to reduce immediately within 2–3 years of smoking
cessation. [15–17]While we are unable to evaluate the pathophys-
iology of the association, smoking is known to affect endothelial
cell function and nitric oxide production leading to vasoconstric-
tion and vascular damage. [18] It is highly conceivable that these
mechanisms contribute, at least in part, to the progressive renal
damage associated with smoking.
It is also important to underscore that the incidence of kidney
failure (674 cases in a cohort of 63,163 over 13.4 years (Table 2)) is
higher in our study than previously reported in European origin
populations such as the MRFIT (814 individuals developed kidney
failure among a cohort of 332,544 men over 16 years), HUNT,
and other studies in European-origin populations, and consistent
with high incidence of kidney failure reported in the Southeast
Asian population in Taiwan. [19,20] It remains to be studied
whether this variation is due to a greater prevalence, faster
progression of CKD, or both, or perhaps improved survival from
competing causes in the Chinese population with a different
sociodemographic profile than their Western counterparts. [21]
Nevertheless our findings indicate that smoking contributes to the
burden of kidney failure.
The major strengths of our findings are the large, representa-
tive, population based cohort with well documented information
on smoking status linked with a robust renal registry, and all results
regarding key relationships with smoking status (dose response
with regard to duration and intensity) were consistent in direction
in sensitivity analysis in the entire cohort. A limitation of the study
is the lack of information on baseline kidney function including
serum creatinine or albuminuria, and non-kidney failure deaths
were censored in the analysis. This precluded evaluation of the
effect of smoking on other causes (especially cardiovascular deaths)
in earlier stages on CKD. Clearly such a relationship will magnify
the detrimental effect of smoking across the spectrum of CKD as
smoking has been shown to predict CVD and cancer deaths in this
cohort. [22] However, our main objective was to determine the
relationship of smoking with kidney failure which we were able to
demonstrate. Second, data on reno-protective antihypertensive
medications including blockers of renin-angiotensin, and reduction
in blood pressure or albuminuria during follow-up were not
available. [23] We were therefore not able to determine any
potential interaction between these factors with smoking status on
kidney failure. However, our multivariable model accounted for
hypertension and diabetes at baseline, both leading causes of
kidney failure, as well as predictors of progression. [11] A third
limitation is the possibility that the observed relationship between
smoking and kidney failure is confounded by unmeasured social
determinant (household income, neighborhood poverty index)
including access to healthcare known to be associated with kidney
failure. [24–27] Nevertheless, the reduction in risk of kidney failure
with smoking cessation is highly suggestive of an independent
predictive and causal nature of the association. Finally the number
of women smokers was too low to detect any significant
associations, and it is possible that clinically meaningful interac-
tions (eg with sociodemographic factors) remained undetected.
Future research on larger pooled data may provide further
valuable insights in potential heterogeneity of the relationship of
smoking with kidney failure in these subgroups.
In summary, our results on analysis of the Singapore Chinese
cohort indicate a strong predictive association of ever smoking
with kidney failure, which increases with the duration of smoking.
This risk reduces back to the level of a non-smoker only after very
prolonged duration of smoking cessation. Our findings have
tremendous implications for public policy globally, especially in
Southeast Asian countries and China. The number of people with
kidney failure in this region is increasing rapidly with aging
populations. Despite the global initiative of the World Health
Assembly and ratification of the Framework Convention on
Tobacco Control (FCTC), over 1 billion people smoke globally, a
substantial proportion of the population of Chinese origin is
exposed. [28,29] Our results suggest that if left unchecked, a
further escalation in the number of people with kidney failure is
expected. Immediate action is therefore needed for intensifying
tobacco control efforts through legislative action, taxation, public
education, collaborative partnership to reduce the supply and
demand of tobacco and provision of smoking cessation services,
and targeted intervention for individuals at high risk of kidney
failure.
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